000 01640 a2200433 4500
005 20250514200108.0
264 0 _c20041101
008 200411s 0 0 eng d
022 _a0085-2538
024 7 _a10.1111/j.1523-1755.2004.00848.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLewko, Barbara
245 0 0 _aC-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress.
_h[electronic resource]
260 _bKidney international
_cSep 2004
300 _a1001-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAtrial Natriuretic Factor
_xpharmacology
650 0 4 _aCell Line, Transformed
_xdrug effects
650 0 4 _aCyclic GMP
_xbiosynthesis
650 0 4 _aGlucose
_xpharmacology
650 0 4 _aGuanylate Cyclase
_xgenetics
650 0 4 _aKidney Glomerulus
_xcytology
650 0 4 _aMice
650 0 4 _aNatriuretic Agents
_xpharmacology
650 0 4 _aNatriuretic Peptide, C-Type
_xgenetics
650 0 4 _aNitroprusside
_xpharmacology
650 0 4 _aRNA, Messenger
_xanalysis
650 0 4 _aReceptors, Atrial Natriuretic Factor
_xgenetics
650 0 4 _aReceptors, G-Protein-Coupled
_xmetabolism
650 0 4 _aStress, Mechanical
650 0 4 _aVasodilator Agents
_xpharmacology
700 1 _aEndlich, Nicole
700 1 _aKriz, Wilhelm
700 1 _aStepinski, Jan
700 1 _aEndlich, Karlhans
773 0 _tKidney international
_gvol. 66
_gno. 3
_gp. 1001-8
856 4 0 _uhttps://doi.org/10.1111/j.1523-1755.2004.00848.x
_zAvailable from publisher's website
999 _c15025228
_d15025228